2023 Q3 Form 10-Q Financial Statement

#000149315223027818 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $186.4K $195.9K $107.00
YoY Change -68.64% 183018.69%
Cost Of Revenue $221.5K $423.0K $3.663K
YoY Change 11448.18%
Gross Profit -$35.11K -$227.1K -$3.556K
YoY Change 6285.55%
Gross Profit Margin -18.84% -115.89% -3323.36%
Selling, General & Admin $1.472M $2.815M $94.87K
YoY Change 11.43% 2866.88% 77.18%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $627.8K $317.6K $210.00
YoY Change 151120.95% 0.0%
% of Gross Profit
Operating Expenses $1.472M $2.815M $128.7K
YoY Change 11.43% 2087.61% 46.14%
Operating Profit -$7.313M -$8.686M -$132.2K
YoY Change -38.65% 6469.52% 50.18%
Interest Expense -$4.990M $39.58K
YoY Change -260253.81%
% of Operating Profit
Other Income/Expense, Net -$4.487M -$6.481M
YoY Change -548.3%
Pretax Income -$11.80M -$15.17M -$132.2K
YoY Change 5.84% 11371.45% -88.35%
Income Tax
% Of Pretax Income
Net Earnings -$11.80M -$15.17M -$131.6K
YoY Change 5.84% 11425.5% -88.41%
Net Earnings / Revenue -6330.08% -7740.69% -122985.05%
Basic Earnings Per Share -$1.09 -$1.49 -$0.02
Diluted Earnings Per Share -$1.09 -$1.49 -$0.02
COMMON SHARES
Basic Shares Outstanding 10.83M shares 10.33M shares 8.400M shares
Diluted Shares Outstanding 10.78M shares 10.21M shares 8.400M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.62K $420.00 $33.49K
YoY Change -98.75% -96.37%
Cash & Equivalents $298.4K $252.6K $33.49K
Short-Term Investments $0.00
Other Short-Term Assets $831.8K $523.1K $51.92K
YoY Change 907.59% 2147.62%
Inventory $14.90K $21.78K $40.90K
Prepaid Expenses
Receivables $1.189M $1.216M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.082M $1.761M $126.3K
YoY Change 36.75% 1294.33% -86.34%
LONG-TERM ASSETS
Property, Plant & Equipment $3.130M $3.272M $1.256K
YoY Change 118.69% 260434.55% -39.9%
Goodwill $5.918M $5.918M
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $540.0K $592.0K
YoY Change
Total Long-Term Assets $8.704M $9.313M
YoY Change 18.16%
TOTAL ASSETS
Total Short-Term Assets $2.082M $1.761M $126.3K
Total Long-Term Assets $8.704M $9.313M
Total Assets $10.79M $11.07M $127.6K
YoY Change 21.34% 8581.41% -86.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.114M $4.317M
YoY Change 1094.79%
Accrued Expenses $672.0K $378.9K $0.00
YoY Change 131.94%
Deferred Revenue
YoY Change
Short-Term Debt $2.072M $762.4K $0.00
YoY Change
Long-Term Debt Due $88.83K $118.0K
YoY Change 108.18%
Total Short-Term Liabilities $33.49M $33.74M $69.82K
YoY Change 3915.8% 48221.59% 47.63%
LONG-TERM LIABILITIES
Long-Term Debt $172.2K $250.5K $0.00
YoY Change 85.8%
Other Long-Term Liabilities $1.527M $1.495M
YoY Change
Total Long-Term Liabilities $1.794M $1.850M $0.00
YoY Change 126.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.49M $33.74M $69.82K
Total Long-Term Liabilities $1.794M $1.850M $0.00
Total Liabilities $35.28M $35.59M $69.82K
YoY Change 2069.96% 50871.86% 47.63%
SHAREHOLDERS EQUITY
Retained Earnings -$86.74M -$74.94M -$4.258M
YoY Change 190.92% 1659.83%
Common Stock $1.930K $1.034K $4.318M
YoY Change -99.99% -99.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$27.75M -$27.76M $59.49K
YoY Change
Total Liabilities & Shareholders Equity $10.79M $11.07M $127.6K
YoY Change 21.34% 8581.41% -86.23%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$11.80M -$15.17M -$131.6K
YoY Change 5.84% 11425.5% -88.41%
Depreciation, Depletion And Amortization $627.8K $317.6K $210.00
YoY Change 151120.95% 0.0%
Cash From Operating Activities -$2.901M -$2.775M -$106.7K
YoY Change 2499.19% 6.24%
INVESTING ACTIVITIES
Capital Expenditures $140.7K $899.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $235.8K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $95.10K -$899.0K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.852M $3.098M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -2.901M -$2.775M -106.7K
Cash From Investing Activities 95.10K -$899.0K 0.000
Cash From Financing Activities 2.852M $3.098M 0.000
Net Change In Cash 45.78K -$575.2K -106.7K
YoY Change 438.79% 169.91%
FREE CASH FLOW
Cash From Operating Activities -$2.901M -$2.775M -$106.7K
Capital Expenditures $140.7K $899.0K $0.00
Free Cash Flow -$3.042M -$3.674M -$106.7K
YoY Change 3341.34% 6.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001589361
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 WTRV Deferred Drilling Costs
DeferredDrillingCosts
usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2022Q2 WTRV Derivative Expense
DerivativeExpense
usd
CY2022Q2 WTRV Amortization Of Debt Discount Convertible Note
AmortizationOfDebtDiscountConvertibleNote
usd
CY2022Q2 WTRV Amortization Of Discount Series C Preferred Stock
AmortizationOfDiscountSeriesCPreferredStock
usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2023Q2 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax
usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2022Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
usd
CY2022Q2 WTRV Derivative Expense
DerivativeExpense
usd
CY2022Q2 WTRV Amortization Of Discounts Convertible Notes
AmortizationOfDiscountsConvertibleNotes
usd
CY2022Q2 WTRV Expense Recorded For Advances From Related Parties
ExpenseRecordedForAdvancesFromRelatedParties
usd
CY2022Q2 WTRV Amortization Of Discount Series C Preferred Stock
AmortizationOfDiscountSeriesCPreferredStock
usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
CY2022Q2 WTRV Increase Decrease In Receivable Participation Agreement
IncreaseDecreaseInReceivableParticipationAgreement
usd
CY2022Q2 WTRV Finance Lease Right Of Use Asset Amortization Expenses
FinanceLeaseRightOfUseAssetAmortizationExpenses
usd
CY2022Q2 WTRV Increase Decrease In Deferred Drilling Costs
IncreaseDecreaseInDeferredDrillingCosts
usd
CY2023Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
CY2022Q2 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
usd
CY2023Q2 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
usd
CY2023Q2 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
usd
CY2022Q2 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
CY2022Q2 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2023Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2022Q2 WTRV Repayment Of Longterm Debt And Note Payable
RepaymentOfLongtermDebtAndNotePayable
usd
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 WTRV Fixed Assets Acquired For Notes Payable And Longterm Debt
FixedAssetsAcquiredForNotesPayableAndLongtermDebt
usd
CY2023Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
CY2022Q2 us-gaap Exploration Costs
ExplorationCosts
usd
CY2023Q2 WTRV Reclassification Of Unevaluated Wells In Progress
ReclassificationOfUnevaluatedWellsInProgress
usd
CY2023Q2 WTRV Asset Retirement Obligation Reclamation Obligations Settled
AssetRetirementObligationReclamationObligationsSettled
usd
CY2022Q2 WTRV Asset Retirement Obligation Reclamation Obligations Settled
AssetRetirementObligationReclamationObligationsSettled
usd
CY2023Q2 WTRV Asset Retirement Obligation Disposition Due To Sale Of Property
AssetRetirementObligationDispositionDueToSaleOfProperty
usd
CY2023Q2 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
usd
CY2022Q2 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
usd
CY2023Q2 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
usd
CY2022Q2 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2022Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Market Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMarketPrice
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionExercisedInPeriod
shares
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercised Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisedDateFairValue
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023Q1 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited Or Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedOrExpiredWeightedAverageExercisePrice
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q2 WTRV Finance Lease Depreciation
FinanceLeaseDepreciation
usd
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
usd
CY2023Q2 WTRV Disposal Group Including Discontinued Operation Other Income Loss
DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
usd
CY2022Q2 WTRV Disposal Group Including Discontinued Operation Other Income Loss
DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
usd
CY2023Q2 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-192060
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
White River Energy Corp
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3797537
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
609 West Dickson St.
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102 G
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Fayetteville
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
AR
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
72701
CY2023Q2 dei City Area Code
CityAreaCode
800
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
203-5610
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10833800 shares
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
252213 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
251778 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
104821 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
113659 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
250519 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208046 usd
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1494944 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
252631 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
827790 usd
CY2023Q1 WTRV Receivable Participation Agreement Currentnet Of Allowance For Doubtful Accounts
ReceivableParticipationAgreementCurrentnetOfAllowanceForDoubtfulAccounts
1440598 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
21777 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
16821 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
270933 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
334264 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1761147 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3631968 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3272314 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3251432 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58764 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
100644 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
165674 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
175139 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1227366 usd
CY2023Q1 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1285177 usd
CY2023Q2 WTRV Unevaluated Wells In Progress
UnevaluatedWellsInProgress
3997074 usd
CY2023Q1 WTRV Unevaluated Wells In Progress
UnevaluatedWellsInProgress
3244653 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
592012 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
630531 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
9313204 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
8687576 usd
CY2023Q2 us-gaap Assets
Assets
11074351 usd
CY2023Q1 us-gaap Assets
Assets
12319544 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4316684 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3501283 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
378930 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
406669 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15254287 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10483371 usd
CY2023Q1 WTRV Deferred Drilling Costs
DeferredDrillingCosts
317350 usd
CY2023Q2 WTRV Preferred Stock Issued
PreferredStockIssued
8774619 usd
CY2023Q1 WTRV Preferred Stock Issued
PreferredStockIssued
6488178 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
762379 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
972831 usd
CY2023Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
117961 usd
CY2023Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
104950 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70763 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
108117 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
33085 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
31629 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
33735720 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
23596628 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2119 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1463931 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1850284 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1787755 usd
CY2023Q2 us-gaap Liabilities
Liabilities
35586004 usd
CY2023Q1 us-gaap Liabilities
Liabilities
25384383 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10333800 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10333800 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10166667 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10166667 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1034 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1017 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47173132 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43453095 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74935820 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59768952 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-27761653 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-16314839 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
3250000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
3250000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-24511653 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13064839 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11074351 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12319544 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195937 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116461 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
105448 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
92543 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
4829951 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
445605 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
814273 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2814530 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1307940 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
317564 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
168864 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
8881766 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
2014952 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8685829 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1898491 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2343320 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
699650 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
160695 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
178777 usd
CY2023Q2 WTRV Increase Decrease In Receivable Participation Agreement
IncreaseDecreaseInReceivableParticipationAgreement
-59971 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4956 usd
CY2023Q2 WTRV Derivative Expense
DerivativeExpense
2427596 usd
CY2023Q2 WTRV Amortization Of Debt Discount Convertible Note
AmortizationOfDebtDiscountConvertibleNote
358194 usd
CY2023Q2 WTRV Amortization Of Discount Series C Preferred Stock
AmortizationOfDiscountSeriesCPreferredStock
1145441 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
56354 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-150134 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2205 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6481039 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2205 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15166868 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1900696 usd
CY2022Q2 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax
-85848 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-85848 usd
CY2023Q2 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
-15166868 usd
CY2022Q2 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
-1986544 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-15166868 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1986544 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15166868 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1986544 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.49
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10208909 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10208909 shares
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8981922 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2597455 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1986544 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9592833 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13064839 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13064839 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3720054 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15166868 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-24511653 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-24511653 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15166868 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1986544 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
317564 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
168864 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3720054 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2055743 usd
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2343320 usd
CY2023Q2 WTRV Derivative Expense
DerivativeExpense
2427596 usd
CY2023Q2 WTRV Amortization Of Discounts Convertible Notes
AmortizationOfDiscountsConvertibleNotes
414548 usd
CY2023Q2 WTRV Expense Recorded For Advances From Related Parties
ExpenseRecordedForAdvancesFromRelatedParties
229635 usd
CY2023Q2 WTRV Amortization Of Discount Series C Preferred Stock
AmortizationOfDiscountSeriesCPreferredStock
1145441 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28981 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-101850 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
648736 usd
CY2023Q2 WTRV Operating Lease Right Of Use Asset Amortization Expenses
OperatingLeaseRightOfUseAssetAmortizationExpenses
-41880 usd
CY2022Q2 WTRV Operating Lease Right Of Use Asset Amortization Expenses
OperatingLeaseRightOfUseAssetAmortizationExpenses
-35652 usd
CY2023Q2 WTRV Finance Lease Right Of Use Asset Amortization Expenses
FinanceLeaseRightOfUseAssetAmortizationExpenses
-9465 usd
CY2023Q2 WTRV Increase Decrease In Deferred Drilling Costs
IncreaseDecreaseInDeferredDrillingCosts
-317350 usd
CY2022Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
2597455 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-39473 usd
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-38476 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
765370 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-638477 usd
CY2023Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
12392231 usd
CY2022Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1286606 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2774637 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-699938 usd
CY2023Q2 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
894386 usd
CY2022Q2 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
999999 usd
CY2023Q2 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
4600 usd
CY2022Q2 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
605600 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-898986 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
394399 usd
CY2022Q2 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
110273 usd
CY2023Q2 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-115199 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2730326 usd
CY2023Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
625000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1141000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
145266 usd
CY2023Q2 WTRV Repayment Of Longterm Debt And Note Payable
RepaymentOfLongtermDebtAndNotePayable
25281 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7382 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3098464 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
255539 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-575159 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
827790 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
251050 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
252631 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
201050 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
165136 usd
CY2023Q2 WTRV Fixed Assets Acquired For Notes Payable And Longterm Debt
FixedAssetsAcquiredForNotesPayableAndLongtermDebt
103058 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
505000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
42253521 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
30000000 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
205.8726308 shares
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
5146816 usd
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
45.64 shares
CY2023Q2 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
1141000 usd
WTRV Warrant To Purchase Shares Percentage
WarrantToPurchaseSharesPercentage
2 pure
WTRV Purchase Price Per Units Of Common Stock
PurchasePricePerUnitsOfCommonStock
25000
CY2023Q2 WTRV Goodwill Impairment
GoodwillImpairment
5917843 usd
CY2023Q2 WTRV Capital Contribution
CapitalContribution
100 usd
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zoRJfUgv2Vjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zOMlqohV0NAk">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reclassified certain amounts in the June 30, 2022 condensed consolidated financial statements to be consistent with the June 30, 2023 presentation. These changes had no impact on the Company’s financial position or result of operations for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z9AlhsRZA649" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: justify; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zC58zbO5tjFi">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, management’s estimate of provisions required for uncollectible accounts receivable, cost allocation percentages, impaired value of equipment and intangible assets, including goodwill, asset retirement obligations, estimates of discount rates in lease, liabilities to accrue, fair value of derivative liabilities associated with warrants and conversion options, cost incurred in the satisfaction of performance obligations, permanent and temporary differences related to income taxes and determination of the fair value of stock awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimates of proved, probable and possible oil and gas reserves are used as significant inputs in determining the depletion of oil and gas properties and the impairment of proved and unproved oil and gas properties. There are numerous uncertainties inherent in the estimation of quantities of proven, probable and possible reserves and in the projection of future rates of production and the timing of development expenditures. Similarly, evaluations for impairment of proved and unproved oil and gas properties are subject to numerous uncertainties including, among others, estimates of future recoverable reserves and commodity price outlooks. Actual results could differ from the estimates and assumptions utilized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Depletion Of Oil And Gas Properties
DepletionOfOilAndGasProperties
57811 usd
CY2022Q2 us-gaap Depletion Of Oil And Gas Properties
DepletionOfOilAndGasProperties
102223 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
141965 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
28265 usd
CY2023Q2 WTRV Percentage Of Present Value Discounted
PercentageOfPresentValueDiscounted
0.10 pure
CY2023Q2 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
141965 usd
CY2022Q2 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
28265 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1325678 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
650562 usd
CY2023Q2 WTRV Reserve For Receivable Under Participation Agreements
ReserveForReceivableUnderParticipationAgreements
1380627 usd
CY2023Q2 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zlHWgNgeMr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zxkkdUUIXpS6">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. Management evaluates all of the Company’s financial instruments, including warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company generally uses a Black-Scholes model, as applicable, to value the derivative instruments at inception and subsequent valuation dates when needed. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-measured at the end of each reporting period. The Black-Scholes model is used to estimate the fair value of the derivative liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
113472 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
67315 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5917843 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
5964000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
5964000 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8400000 shares
CY2022Q3 us-gaap Share Price
SharePrice
0.71
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4 usd
CY2023Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
116461 usd
CY2023Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1986544 usd
CY2023Q1 WTRV Unevaluated Wells In Progress
UnevaluatedWellsInProgress
3244653 usd
CY2022Q1 WTRV Unevaluated Wells In Progress
UnevaluatedWellsInProgress
4936352 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3624816 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3517159 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
352502 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
265727 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3272314 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3251432 usd
CY2023Q2 us-gaap Depreciation
Depreciation
86775 usd
CY2022Q2 us-gaap Depreciation
Depreciation
20030 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
9192576 usd
CY2023Q1 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
9050611 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Depletion
OilAndGasPropertyFullCostMethodDepletion
7965210 usd
CY2023Q1 us-gaap Oil And Gas Property Full Cost Method Depletion
OilAndGasPropertyFullCostMethodDepletion
7765434 usd
CY2023Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1227366 usd
CY2023Q1 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1285177 usd
CY2023Q2 us-gaap Depletion Of Oil And Gas Properties
DepletionOfOilAndGasProperties
57811 usd
CY2022Q2 us-gaap Depletion Of Oil And Gas Properties
DepletionOfOilAndGasProperties
102223 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
141965 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
28265 usd
CY2023Q2 us-gaap Exploration Costs
ExplorationCosts
752421 usd
CY2022Q2 WTRV Reclassification Of Unevaluated Wells In Progress
ReclassificationOfUnevaluatedWellsInProgress
-28265 usd
CY2023Q2 WTRV Unevaluated Wells In Progress
UnevaluatedWellsInProgress
3997074 usd
CY2022Q2 WTRV Unevaluated Wells In Progress
UnevaluatedWellsInProgress
4908087 usd
CY2023Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1463931 usd
CY2022Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1303751 usd
CY2023Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
31013 usd
CY2022Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
18346 usd
CY2022Q2 WTRV Asset Retirement Obligation Disposition Due To Sale Of Property
AssetRetirementObligationDispositionDueToSaleOfProperty
-576036 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1494944 usd
CY2022Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
746061 usd
CY2023Q2 WTRV Percentage Of Discounted
PercentageOfDiscounted
0.08 pure
CY2022Q2 WTRV Percentage Of Discounted
PercentageOfDiscounted
0.08 pure
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
368480 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
312996 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
117961 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
104950 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
250519 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208046 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
117961 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
112835 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
77783 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
24334 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
18626 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
16941 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
368480 usd
CY2023Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
10042 usd
CY2022Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
2421 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
39584 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
56354 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
358194 usd
CY2023Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
625000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.66 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.97 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0360 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0543 pure
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15254287 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10483371 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10483371 usd
CY2023Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2427596 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2343320 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15254287 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2343320 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
505000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 WTRV Description Of Restricted Shares Of Common Stock
DescriptionOfRestrictedSharesOfCommonStock
None of the 17,450,000 restricted shares of common stock have been issued by the transfer agent as of November 30, 2022, and on November 15, 2022, 25,000 of these service-based shares were cancelled as the employee terminated their employment prior to any issuance or vesting of those shares. None of the shares have vested.
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
6150000 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75000 usd
CY2023Q2 WTRV Allocated Share Based Compensation Expense Unrecognized
AllocatedShareBasedCompensationExpenseUnrecognized
18181337 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
17425000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.91
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
1568250
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
6150000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.23
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodTotalFairValue
P5Y7M28D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
636000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1962500 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.23
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
21612500 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.20
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M4D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
6386250
CY2023Q2 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
The lower of (i) $1.00 and (ii) an amount equal to 80% of the 30-day VWAP of the common stock as reported on the Principal Market
CY2023Q2 WTRV Warrant Outstanding
WarrantOutstanding
0.25 pure
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8774619 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
12575632 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10293632 shares
CY2023Q1 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
1.00
CY2023 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm
P4Y7M2D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
2282000 shares
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice
1.00
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageRemainingContractualTerm
P5Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
12575632 shares
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
1.00
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm
P4Y5M4D
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
3018152 usd
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
12575632 shares
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
1.00
CY2023Q2 WTRV Share Based Compensation Arrangement Exercisable By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementExercisableByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm1
P4Y5M4D
CY2023Q2 WTRV Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue
3018152 usd
CY2023Q2 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
For the expected term of the lease the Company used the initial terms ranging between 36 and 48 months.
CY2023Q2 WTRV Unamortized Operating Lease Right Of Use Asset
UnamortizedOperatingLeaseRightOfUseAsset
224438 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
165674 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58764 usd
CY2023Q2 WTRV Lease Liability
LeaseLiability
208669 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
137906 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
70763 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
71272 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
509 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
70763 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70763 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
55427 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
55427 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
55427 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
18476 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
46851 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
137906 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
33085 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
104821 usd
CY2023Q2 WTRV Right Of Use Asset Amortization Remainder Of Fiscal Year
RightOfUseAssetAmortizationRemainderOfFiscalYear
100179 usd
CY2023Q2 WTRV Right Of Use Asset Amortization Next Twelve Months
RightOfUseAssetAmortizationNextTwelveMonths
47938 usd
CY2023Q2 WTRV Right Of Use Asset Amortization Next Two
RightOfUseAssetAmortizationNextTwo
55746 usd
CY2023Q2 WTRV Right Of Use Asset Amortization Year Three
RightOfUseAssetAmortizationYearThree
20575 usd
CY2023Q2 WTRV Unamortized Operating Lease Right Of Use Asset
UnamortizedOperatingLeaseRightOfUseAsset
224438 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
36122 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
36122 usd
CY2023Q2 WTRV Finance Lease Depreciation
FinanceLeaseDepreciation
9465 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6475 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
52062 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
36122 usd
CY2023Q2 WTRV Outstanding Shares Percentage
OutstandingSharesPercentage
0.1536 pure
CY2023Q2 us-gaap Partners Capital Account Description Of Partnership Interest
PartnersCapitalAccountDescriptionOfPartnershipInterest
The Company has formally committed to purchasing these working interests at a PV20 valuation by an independent firm. The PV20 valuation would be the present value of the remaining net cash flows from the WR Fund’s pro rata share of each oil well it has invested in during the term, discounted by 20%. The managing partner of the WR Fund, which is a wholly-owned subsidiary of the Company, shall receive a ten percent (10%) carried interest, payable starting after all investor partners have received a return of capital. In addition to the offer to purchase, each partner will have the option to remain a partner or exchange the partnership unit for a new partnership in a new fund the Company is offering.
CY2023Q1 WTRV Prepaid Operating Transactional Expenses
PrepaidOperatingTransactionalExpenses
60000 usd
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
500000 usd
CY2023Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
299032 usd
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
212 usd
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
86060 usd
CY2022Q2 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax
-85848 usd

Files In Submission

Name View Source Status
0001493152-23-027818-index-headers.html Edgar Link pending
0001493152-23-027818-index.html Edgar Link pending
0001493152-23-027818.txt Edgar Link pending
0001493152-23-027818-xbrl.zip Edgar Link pending
ex10-10.htm Edgar Link pending
ex10-11.htm Edgar Link pending
ex10-12.htm Edgar Link pending
ex10-13.htm Edgar Link pending
ex10-7.htm Edgar Link pending
ex10-8.htm Edgar Link pending
ex10-9.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wtrv-20230630.xsd Edgar Link pending
wtrv-20230630_def.xml Edgar Link unprocessable
wtrv-20230630_lab.xml Edgar Link unprocessable
wtrv-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
wtrv-20230630_cal.xml Edgar Link unprocessable